Cargando…
Oridonin enhances the anti-tumor activity of gemcitabine towards pancreatic cancer by stimulating Bax- and Smac-dependent apoptosis
BACKGROUND: Oridonin has been shown to exhibit potent anti-tumor activity, but the exact mechanisms underlying this activity remains unclear. Here, we investigated whether oridonin could synergistically enhance the activity of gemcitabine against BxPC-3 pancreatic cancer cells. METHODS: CCK-8 assays...
Autores principales: | Liu, Dian-Lei, Bu, He-Qi, Wang, Wen-Long, Luo, Hua, Cheng, Bo-Ning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798810/ https://www.ncbi.nlm.nih.gov/pubmed/35117784 http://dx.doi.org/10.21037/tcr-19-3000 |
Ejemplares similares
-
SapC-DOPS nanovesicles induce Smac- and Bax-dependent apoptosis through mitochondrial activation in neuroblastomas
por: Sulaiman, Mahaboob K, et al.
Publicado: (2015) -
BAX and SMAC regulate bistable properties of the apoptotic caspase system
por: McKenna, Stephanie, et al.
Publicado: (2021) -
SmacN7 enhances the sensitivity of pancreatic cancer cells to tumor necrosis factor-related apoptosis-inducing ligand or gemcitabine
por: ZHOU, WUYUAN, et al.
Publicado: (2013) -
Effect of transgenic Leishmania major expressing mLLO-Bax-Smac fusion gene in the apoptosis of the infected macrophages
por: Aghaei, Maryam, et al.
Publicado: (2021) -
NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
por: Lin, Chao, et al.
Publicado: (2012)